We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$3.79B
AUM Growth
+$6.57M
Cap. Flow
-$29.8M
Cap. Flow %
-0.79%
Top 10 Hldgs %
19.67%
Holding
225
New
3
Increased
32
Reduced
59
Closed
3

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$12.9M
2
EXAS
Exact Sciences
EXAS
+$12.7M
3
DAL icon
Delta Air Lines
DAL
+$6.94M
4
ATVI
Activision Blizzard
ATVI
+$6.27M
5
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$5.2M

Top Sells

Rank Stock Value
1
ZEN
ZENDESK INC
ZEN
+$12.4M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$9.74M
3
ANSS
Ansys
ANSS
+$8.61M
4
TDY icon
Teledyne Technologies
TDY
+$7.42M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 34%
2 Healthcare 17.11%
3 Industrials 15.63%
4 Financials 11.96%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLGN icon
126
Silgan Holdings
SLGN
$4.23B
$7.31M 0.19%
190,600
-45
-0% -$1.83K
AVGO icon
127
Broadcom
AVGO
$1.85T
$7.28M 0.19%
150,100
+10
+0% +$486
DAL icon
128
Delta Air Lines
DAL
$57.5B
$7.24M 0.19%
+170,000
New +$6.94M
GPN icon
129
Global Payments
GPN
$23B
$7.23M 0.19%
45,887
– –
HLT icon
130
Hilton Worldwide
HLT
$72.1B
$7.13M 0.19%
54,000
– –
CRL icon
131
Charles River Laboratories
CRL
$11.2B
$7.01M 0.19%
17,000
– –
UNH icon
132
UnitedHealth
UNH
$376B
$6.96M 0.18%
17,803
-5
-0% -$2.07K
PGR icon
133
Progressive
PGR
$123B
$6.89M 0.18%
76,200
– –
ICUI icon
134
ICU Medical
ICUI
$4.21B
$6.75M 0.18%
28,900
– –
PAYC icon
135
Paycom
PAYC
$7.64B
$6.64M 0.18%
13,400
– –
CSL icon
136
Carlisle Companies
CSL
$14.3B
$6.6M 0.17%
33,200
– –
HD icon
137
Home Depot
HD
$331B
$6.57M 0.17%
20,000
-1,000
-5% -$328K
TREX icon
138
Trex
TREX
$4.51B
$6.52M 0.17%
64,000
– –
ENS icon
139
EnerSys
ENS
$6.78B
$6.38M 0.17%
85,736
+3
+0% +$266
KWR icon
140
Quaker Houghton
KWR
$2.76B
$6.35M 0.17%
26,700
– –
RPD icon
141
Rapid7
RPD
$645M
$5.81M 0.15%
51,400
– –
ZD icon
142
Ziff Davis
ZD
$1.96B
$5.37M 0.14%
45,195
– –
MTN icon
143
Vail Resorts
MTN
$5.32B
$5.35M 0.14%
16,009
– –
ENSG icon
144
The Ensign Group
ENSG
$10.4B
$5.34M 0.14%
71,300
– –
LSTR icon
145
Landstar System
LSTR
$5.93B
$5.33M 0.14%
33,800
– –
EFX icon
146
Equifax
EFX
$20.3B
$5.2M 0.14%
20,500
– –
MNRO icon
147
Monro
MNRO
$383M
$5.17M 0.14%
89,900
– –
HELE icon
148
Helen of Troy
HELE
$644M
$5.17M 0.14%
23,000
– –
LCII icon
149
LCI Industries
LCII
$2.49B
$5.12M 0.14%
38,021
+21
+0.1% +$2.9K
CNXC icon
150
Concentrix
CNXC
$1.5B
$5.04M 0.13%
28,500
– –
4 5
6
7 8

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, EULAV Asset Management held 225 positions worth $3.79B, up 0.17% from $3.78B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.7%. EULAV Asset Management opened 3 new positions and exited 3, leaving the 225-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.

  • EULAV Asset Management's largest Q3 2021 buy was Edwards Lifesciences: 113,010 shares worth $12.8M.
  • EULAV Asset Management added most to Exact Sciences in Q3 2021, an estimated $12.7M increase.
  • EULAV Asset Management's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $9.74M.
  • EULAV Asset Management fully exited ZENDESK INC in Q3 2021, selling an estimated $12.4M.
  • EULAV Asset Management's ten largest holdings make up 20% of its $3.79B portfolio in Q3 2021.
  • EULAV Asset Management opened 3 new positions and closed 3 in Q3 2021.
  • EULAV Asset Management's portfolio value rose 0.17% quarter-over-quarter to $3.79B.

Based on EULAV Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.